Genetic Biomarkers Market - By Product , By Type , By Test Type , By Application , By Disease indication , By Geography - Global Opportunity Analysis & Industry Forecast, 2024-2030

Report Code: HCR 1265 Report Format: PDF + Excel

Genetic Biomarkers Market Overview

Genetic Biomarkers market size is forecast to reach US$37 billion by 2030, after growing at a CAGR of 9.7% during 2024-2030. Biomarkers are indicators of pathogenic processes, biological processes or pharmacological responses to a therapy. It has various applications in differential diagnosis, prognosis, risk assessment, therapeutic response and monitoring of disease progression. Increasing prevalence of chronic diseases and the growing awareness of early disease detection are the primary drivers of the genetic biomarkers market. Additionally, the launch of biomarker tests by key players is also driving the market's growth. For example, in March 2024, Labcorp launched its standalone phosphorylated tau 218 (pTau218) blood biomarker test, for the diagnosis of Alzheimer’s.

A significant trend is utilizing genetic biomarkers for early detection and risk assessment of complex diseases like cancer and cardiovascular conditions.  For example, in February 2023, The National Institute of Health announced a $4 million funding to Eastern Virginia Medical School (EVMS) for research and development of biomarker for early detection of aggressive prostate cancer. The expansion of biopharmaceutical research is also fueling the development of novel biomarker which paves the way for targeted therapies and improved patient outcomes. The focus is shifting towards multi-omics approaches that integrate genomics, proteomics and metabolomics thereby providing a comprehensive understanding of disease mechanisms.

Market Snapshot: 


Genetic Biomarkers Market

Genetic Biomarkers Market - Report Coverage:

The “Genetic Biomarkers Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Genetic Biomarkers Market.

Attribute Segment

By Product
  • Consumables
  • Services
  • Software

By Type
  • Safety Biomarkers
  • Efficacy Biomarkers
  • Validation Biomarkers

By Test Type
  • Population Screening
  • Diagnostic Testing
  • Others

By Application
  • Diagnostics
  • Drug Discovery and Development
  • Personalized Medicine
  • Disease Risk Assessment
  • Others

By Disease/Indication
  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Immunological Disorders
  • Others

By End Users
  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others

By Geography

  • North America (U.S, Canada and Mexico)
  • Europe (Germany, France, UK, Italy, Spain, Netherlands, Belgium and Rest of Europe),
  • Asia-Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia and Rest of Asia-Pacific),
  • South America (Brazil, Argentina, Chile, Colombia and Rest of South America)
  • Rest of the World (Middle East and Africa).

COVID-19 / Ukraine Crisis - Impact Analysis:  

  • The COVID-19 pandemic accelerated research and development in genetic biomarkers. Scientists focused on identifying genetic factors associated with susceptibility, severity and recovery from the virus. This led to the discovery of genetic markers that could predict the risk of developing severe COVID-19 or experiencing long-term complications.
  • The Russia-Ukraine war has indirectly impacted the research and development of genetic biomarkers. As countries focus on defense spending and aid packages to Ukraine, significant budget cuts are imposed on research funding which could hinder progress in genetic biomarker research.

Key Takeaways

  • Drug Discovery and Development Dominates the Market

The Drug discovery and development segment dominates the Genetic Biomarkers market. Genetic biomarkers are crucial in identifying target populations, predicting drug responses and assessing toxicity. This helps in developing more effective and safer drugs. By enabling the selection of appropriate patients for clinical trials, biomarkers reduce trial sizes and duration which lowers costs and increases the likelihood of success. Pharmaceutical companies are increasingly relying on biomarkers to identify new drug targets and understand disease mechanisms. In May 2024, NeuroSense shared biomarker data from the Phase II PARADIGM study of PrimeC for ALS. PrimeC regulated iron levels and slowed disease progression by 36% over 12 months, demonstrating the potential for biomarkers to guide the development of disease-modifying therapies. Therefore, drug discovery and development will continue to be the largest application of genetic biomarkers market during the forecast period.

Cancer is the largest segment

Cancer is the largest segment in the Genetic Biomarkers market. According to the World Health Organization (WHO), there were an estimated 20 million new cases of cancer and 9.7 million deaths from cancer in 2022. As per WHO predictions, cancer will increase by about 77% by 2050. Biomarkers play an important in oncology for early detection, diagnosis, prognosis and treatment. Genetic biomarkers have become indispensable in identifying specific mutations and genetic alterations associated with different types of cancers. This has led to the development of targeted therapies such as HER2-positive breast cancer or EGFR-mutated lung cancer which rely heavily on precise biomarker identification. The ongoing research into cancer genomics identifies new biomarkers that can predict responses to therapies, identify resistance mechanisms and monitor disease progression.

North America Dominates the market

The Genetic Biomarkers market is dominated by the North American region with a market share of 41% in 2023 primarily due to its growing R&D investment in disease management and the presence of major industry players. Leading companies such as Thermo Fisher, Illumina, Bio-Rad Laboratories, among others which are headquartered in North America, drive innovation and adoption in this sector. Additionally, the region's regulatory environment with agencies like the FDA providing clear guidelines for biomarker use in drug development and clinical trials, encourages the use of biomarkers. This provides a favorable market to launch biomarker tests. In August 2023, Quest Diagnostics partnered with Envision Sciences to commercially launch a novel prostate cancer biomarker test in the US market to help in identifying patients with more aggressive forms of the disease. Furthermore, the high prevalence of chronic diseases such as cancer and cardiovascular diseases in the region also fuels demand for genetic biomarkers in diagnostic and therapeutic applications.

Increasing Prevalence of Chronic Diseases is a Major Driver

Chronic diseases are a major public health challenge. As longevity increases people are more likely to develop chronic diseases. The shift from rural to urban living is associated with an increase in risk factors for chronic diseases such as unhealthy diet, physical inactivity and tobacco use. Along with the above-mentioned factors, a sedentary lifestyle with high-fat, high-sugar diets are contributing to the rise of chronic diseases in low- and middle-income countries. The World Health Organization (WHO) warns that NCDs, including cardiovascular diseases, cancer, diabetes and respiratory illnesses, will account for 86% of the 90 million deaths annually by 2050. The growing prevalence of chronic diseases demands new drugs which drives the genetic biomarkers market

Growing Awareness of Early Disease Detection Drives the Market

The increasing awareness of the importance of early disease detection is an important driver in the genetic biomarkers market. As healthcare systems worldwide shift towards preventative care there is a growing emphasis on identifying diseases at their earliest as in the early stages there is a very high chance of successful treatment. Genetic biomarkers play a crucial role in this by enabling the detection of genetic changes associated with various conditions long before clinical symptoms appear. As per the cancer survival estimates according to stage at diagnosis published by the Office for National Statistics, for most cancers, survival at one and five years is much higher if the cancer is detected early (at stage 1) than if it is detected later. For example, early-stage detection (stage 1) of ovarian cancer has a survival rate of 92%, compared to only 6% for late-stage detection (stage 4). Early detection not only improves patient outcomes by allowing for timely interventions but also reduces healthcare costs which further drives the adoption of genetic biomarkers in diagnostic applications.


Genetic Biomarkers Market

For more details on this report - Request for Sample

Key Market Players

Global Genetic Biomarkers top 10 companies include:

  1. Illumina Inc.
  2. Thermo Fisher Scientific Inc.
  3. Bio-Rad Laboratories, Inc.
  4. Abbott
  5. F. Hoffmann-La Roche
  6. QIAGEN
  7. PerkinElmer
  8. Hologic, Inc.
  9. Myriad Genetics, Inc.
  10. Genomic Health, Inc.

Scope of the Report: 

Report Metric Details

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

9.7%

Market Size in 2030

$37 Billion

Segments Covered

By Product, By Type, By Test Type, By Application, By Disease Indication and By Geography.

 

Geographies Covered

North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa).

Key Market Players
  1. Illumina Inc.
  2. Thermo Fisher Scientific Inc.
  3. Bio-Rad Laboratories, Inc.
  4. Abbott
  5. F. Hoffmann-La Roche
  6. QIAGEN
  7. PerkinElmer
  8. Hologic, Inc.
  9. Myriad Genetics, Inc.
  10. Genomic Health, Inc.

For more Lifesciences and Healthcare Market reports, please click here

  1. Genetic Biomarkers Market- Market Overview
          1.1 Definitions and Scope
  2. Genetic Biomarkers Market - Executive Summary
          2.1 Key Trends by Product
          2.2 Key Trends by Type
          2.3 Key Trends by Test Type
          2.4 Key Trends by Application
          2.5 Key Trends by Disease/Indication
          2.6 Key Trends by End User
          2.7 Key Trends by Geography
  3. Genetic Biomarkers Market – Comparative analysis
          3.1 Market Share Analysis- Major Companies
          3.2 Product Benchmarking- Major Companies
          3.3 Top 5 Financials Analysis
          3.4 Patent Analysis- Major Companies
          3.5 Pricing Analysis (ASPs will be provided)
  4. Genetic Biomarkers Market - Startup Companies Scenario 
          4.1 Major startup company analysis:
                    4.1.1 Investment
                    4.1.2 Revenue
                    4.1.3 Product portfolio
                    4.1.4 Venture Capital and Funding Scenario
  5. Genetic Biomarkers Market – Industry Market Entry Scenario Premium 
          5.1 Regulatory Framework Overview
          5.2 New Business and Ease of Doing Business Index
          5.3 Successful Venture Profiles
          5.4 Customer Analysis – Major companies
  6. Genetic Biomarkers Market - Market Forces
          6.1 Market Drivers
          6.2 Market Constraints
          6.3 Porters Five Force Model
                    6.3.1 Bargaining Power of Suppliers
                    6.3.2 Bargaining Powers of Buyers
                    6.3.3 Threat of New Entrants
                    6.3.4 Competitive Rivalry
                    6.3.5 Threat of Substitutes
  7. Genetic Biomarkers Market – Strategic Analysis
          7.1 Value/Supply Chain Analysis
          7.2 Opportunity Analysis
          7.3 Product/Market Life Cycle
          7.4 Distributor Analysis – Major Companies
  8. Genetic Biomarkers Market – By Product (Market Size -US$ Million/Billion)
          8.1 Consumables
                   8.1.1 Reagents
                  8.1.2 Assay Kits
                 8.1.3 Others
          8.2 Services
          8.3 Software
  9. Genetic Biomarkers Market – By Type (Market Size -US$ Million/Billion)
          9.1 Safety Biomarkers
          9.2 Efficacy Biomarkers
                   9.2.1 Prognostic Biomarkers
                   9.2.2 Pharmacodynamic Biomarkers
                   9.2.3 Surrogate End Point Markers
                   9.2.4 Predictive Biomarkers
          9.3 Validation Biomarkers
  10. Genetic Biomarkers Market – By Test Type (Market Size - US$ Million/Billion)
          10.1 Population Screening
          10.2 Diagnostic Testing 
          10.3 Others
  11. Genetic Biomarkers Market – By Disease/Indication (Market Size - US$ Million/Billion)
           11.1 Cancer
                      11.1.1 Breast Cancer
                      11.1.2 Gastrointestinal Cancer
                      11.1.3 Lung Cancer
                      11.1.4 Ovarian Cancer
                      11.1.5 Melanoma
                      11.1.6 Prostate Cancer
                       11.1.7 Others
      11.2 Cardiovascular Disorders
      11.3 Neurological Disorders
      11.5 Immunological Disorders
      11.6 Others
  12. Genetic Biomarkers Market – By Application (Market Size -US$ Million/Billion)
          12.1 Diagnostics
          12.2 Drug Discovery and Development
          12.3 Personalized Medicine
          12.4 Disease Risk Assessment
          12.5 Others
  13. Genetic Biomarkers Market – By End Users (Market Size -US$ Million/Billion)
         13.1 Hospitals & Clinics 
         13.2 Diagnostic Laboratories
         13.3 Research & Academic Institutes
         13.4 Pharmaceutical & Biotechnology Companies
         13.5 Others
  14. Genetic Biomarkers Market - By Geography (Market Size -US$ Million/Billion)
          14.1 North America
                    14.1.1 USA
                    14.1.2 Canada
                    14.1.3 Mexico
          14.2 Europe
                    14.2.1 UK
                    14.2.2 Germany
                    14.2.3 France
                    14.2.4 Italy
                    14.2.5 Netherlands
                    14.2.6 Spain
                    14.2.7 Denmark
                    14.2.8 Belgium
                    14.2.9 Rest of Europe
          14.3 Asia-Pacific
                    14.3.1 China
                    14.3.2 Japan
                    14.3.3 India
                    14.3.4 South Korea
                    14.3.5 Australia and New Zealand
                    14.3.6 Indonesia
                    14.3.7 Thailand
                    14.3.8 Malaysia
                    14.3.9 Rest of APAC
          14.4 South America
                    14.4.1 Brazil
                    14.4.2 Argentina
                    14.4.3 Colombia
                    14.4.4 Chile
                    14.4.5 Rest of South America
          14.5 Rest of the World
                    14.5.1 Middle East
                    14.5.2 Africa
  15. Genetic Biomarkers Market – Entropy
          15.1 New Product Launches
          15.2 M&As, Collaborations, JVs and Partnerships
  16. Genetic Biomarkers Market – Industry/Segment Competition Landscape 
          16.1 Company Benchmarking Matrix – Major Companies
          16.2 Market Share at Global Level – Major companies
          16.3 Market Share by Key Region – Major companies
          16.4 Market Share by Key Country – Major companies
          16.5 Market Share by Key Application – Major companies
  17. Genetic Biomarkers Market – Key Company List by Country Premium 
  18. Genetic Biomarkers Market Company Analysis - Business Overview, Product Portfolio, Financials, and Developments
          18.1 Illumina Inc.
          18.2 Thermo Fisher Scientific Inc
          18.3    Bio-Rad Laboratories, Inc.
          18.4    Abbott
          18.5    F.Hoffmann-La Roche
          18.6    QIAGEN
          18.7    PerkinElmer
          18.8    Hologic, Inc.
          18.9    Myriad Genetics, Inc.
         18.10 Genomic Health, Inc.
  “Financials to the Private Companies would be provided on best-effort basis.”
  Connect with our experts to get customized reports that best suit your requirements. Our reports include global-level data, niche markets and competitive landscape.

List of Tables:

Table1: Genetic Biomarkers Market Overview 2023-2030
Table2: Genetic Biomarkers Market Leader Analysis 2023-2030 (US$)
Table3: Genetic Biomarkers Market Product Analysis 2023-2030 (US$)
Table4: Genetic Biomarkers Market End User Analysis 2023-2030 (US$)
Table5: Genetic Biomarkers Market Patent Analysis 2013-2023* (US$)
Table6: Genetic Biomarkers Market Financial Analysis 2023-2030 (US$)
Table7: Genetic Biomarkers Market Driver Analysis 2023-2030 (US$)
Table8: Genetic Biomarkers Market Challenges Analysis 2023-2030 (US$)
Table9: Genetic Biomarkers Market Constraint Analysis 2023-2030 (US$)
Table10: Genetic Biomarkers Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table11: Genetic Biomarkers Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table12: Genetic Biomarkers Market Threat of Substitutes Analysis 2023-2030 (US$)
Table13: Genetic Biomarkers Market Threat of New Entrants Analysis 2023-2030 (US$)
Table14: Genetic Biomarkers Market Degree of Competition Analysis 2023-2030 (US$)
Table15: Genetic Biomarkers Market Value Chain Analysis 2023-2030 (US$)
Table16: Genetic Biomarkers Market Pricing Analysis 2023-2030 (US$)
Table17: Genetic Biomarkers Market Opportunities Analysis 2023-2030 (US$)
Table18: Genetic Biomarkers Market Product Life Cycle Analysis 2023-2030 (US$)
Table19: Genetic Biomarkers Market Supplier Analysis 2023-2030 (US$)
Table20: Genetic Biomarkers Market Distributor Analysis 2023-2030 (US$)
Table21: Genetic Biomarkers Market Trend Analysis 2023-2030 (US$)
Table22: Genetic Biomarkers Market Size 2023 (US$)
Table23: Genetic Biomarkers Market Forecast Analysis 2023-2030 (US$)
Table24: Genetic Biomarkers Market Sales Forecast Analysis 2023-2030 (Units)
Table25: Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table26: Genetic Biomarkers Market By Type, Revenue & Volume, By Safety Biomarkers, 2023-2030 ($)
Table27: Genetic Biomarkers Market By Type, Revenue & Volume, By Efficacy Biomarkers, 2023-2030 ($)
Table28: Genetic Biomarkers Market By Type, Revenue & Volume, By Validation Biomarkers, 2023-2030 ($)
Table29: Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table30: Genetic Biomarkers Market By Test Type, Revenue & Volume, By Diagnostic Testing, 2023-2030 ($)
Table31: Genetic Biomarkers Market By Test Type, Revenue & Volume, By Population Screening, 2023-2030 ($)
Table32: Genetic Biomarkers Market By Test Type, Revenue & Volume, By Predictive Testing, 2023-2030 ($)
Table33: Genetic Biomarkers Market By Test Type, Revenue & Volume, By Carrier Screening, 2023-2030 ($)
Table34: Genetic Biomarkers Market By Test Type, Revenue & Volume, By Prenatal Testing, 2023-2030 ($)
Table35: Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table36: Genetic Biomarkers Market By Application, Revenue & Volume, By Drug Discovery and Development, 2023-2030 ($)
Table37: Genetic Biomarkers Market By Application, Revenue & Volume, By Personalized Medicine, 2023-2030 ($)
Table38: Genetic Biomarkers Market By Application, Revenue & Volume, By Disease Risk Assessment, 2023-2030 ($)
Table39: Genetic Biomarkers Market By Application, Revenue & Volume, By Oncology Treatment, 2023-2030 ($)
Table40: Genetic Biomarkers Market By Application, Revenue & Volume, By Cardiovascular Treatment, 2023-2030 ($)
Table41: Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table42: Genetic Biomarkers Market By Disease Indication, Revenue & Volume, By Neurological Disorders, 2023-2030 ($)
Table43: Genetic Biomarkers Market By Disease Indication, Revenue & Volume, By Immunological Disorders, 2023-2030 ($)
Table44: Genetic Biomarkers Market By Disease Indication, Revenue & Volume, By Oncology, 2023-2030 ($)
Table45: Genetic Biomarkers Market By Disease Indication, Revenue & Volume, By Cardiovascular Disorders, 2023-2030 ($)
Table46: Genetic Biomarkers Market By Disease Indication, Revenue & Volume, By Respiratory Diseases, 2023-2030 ($)
Table47: North America Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table48: North America Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table49: North America Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table50: North America Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table51: South america Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table52: South america Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table53: South america Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table54: South america Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table55: Europe Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table56: Europe Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table57: Europe Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table58: Europe Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table59: APAC Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table60: APAC Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table61: APAC Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table62: APAC Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table63: Middle East & Africa Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table64: Middle East & Africa Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table65: Middle East & Africa Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table66: Middle East & Africa Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table67: Russia Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table68: Russia Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table69: Russia Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table70: Russia Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table71: Israel Genetic Biomarkers Market, Revenue & Volume, By Type, 2023-2030 ($)
Table72: Israel Genetic Biomarkers Market, Revenue & Volume, By Test Type, 2023-2030 ($)
Table73: Israel Genetic Biomarkers Market, Revenue & Volume, By Application, 2023-2030 ($)
Table74: Israel Genetic Biomarkers Market, Revenue & Volume, By Disease Indication, 2023-2030 ($)
Table75: Top Companies 2023 (US$) Genetic Biomarkers Market, Revenue & Volume
Table76: Product Launch 2023-2030 Genetic Biomarkers Market, Revenue & Volume
Table77: Mergers & Acquistions 2023-2030 Genetic Biomarkers Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Genetic Biomarkers Market 2023-2030
Figure 2: Market Share Analysis for Genetic Biomarkers Market 2023 (US$)
Figure 3: Product Comparison in Genetic Biomarkers Market 2023-2030 (US$)
Figure 4: End User Profile for Genetic Biomarkers Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Genetic Biomarkers Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Genetic Biomarkers Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Genetic Biomarkers Market 2023-2030
Figure 8: Ecosystem Analysis in Genetic Biomarkers Market 2023
Figure 9: Average Selling Price in Genetic Biomarkers Market 2023-2030
Figure 10: Top Opportunites in Genetic Biomarkers Market 2023-2030
Figure 11: Market Life Cycle Analysis in Genetic Biomarkers Market
Figure 12: GlobalBy Type Genetic Biomarkers Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy Test Type Genetic Biomarkers Market Revenue, 2023-2030 ($)
Figure 14: GlobalBy Application Genetic Biomarkers Market Revenue, 2023-2030 ($)
Figure 15: GlobalBy Disease Indication Genetic Biomarkers Market Revenue, 2023-2030 ($)
Figure 16: Global Genetic Biomarkers Market - By Geography
Figure 17: Global Genetic Biomarkers Market Value & Volume, By Geography, 2023-2030 ($) 
Figure 18: Global Genetic Biomarkers Market CAGR, By Geography, 2023-2030 (%)
Figure 19: North America Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 20: US Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 21: US GDP and Population, 2023-2030 ($)
Figure 22: US GDP – Composition of 2023, By Sector of Origin
Figure 23: US Export and Import Value & Volume, 2023-2030 ($)
Figure 24: Canada Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 25: Canada GDP and Population, 2023-2030 ($)
Figure 26: Canada GDP – Composition of 2023, By Sector of Origin
Figure 27: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 28: Mexico Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 29: Mexico GDP and Population, 2023-2030 ($)
Figure 30: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 31: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 32: South America Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 33: Brazil Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 34: Brazil GDP and Population, 2023-2030 ($)
Figure 35: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 36: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 37: Venezuela Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 38: Venezuela GDP and Population, 2023-2030 ($)
Figure 39: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 40: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 41: Argentina Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 42: Argentina GDP and Population, 2023-2030 ($)
Figure 43: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 44: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 45: Ecuador Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 46: Ecuador GDP and Population, 2023-2030 ($)
Figure 47: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 48: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 49: Peru Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 50: Peru GDP and Population, 2023-2030 ($)
Figure 51: Peru GDP – Composition of 2023, By Sector of Origin
Figure 52: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 53: Colombia Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 54: Colombia GDP and Population, 2023-2030 ($)
Figure 55: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 56: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 57: Costa Rica Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 58: Costa Rica GDP and Population, 2023-2030 ($)
Figure 59: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 60: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 61: Europe Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 62: U.K Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 63: U.K GDP and Population, 2023-2030 ($)
Figure 64: U.K GDP – Composition of 2023, By Sector of Origin
Figure 65: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 66: Germany Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 67: Germany GDP and Population, 2023-2030 ($)
Figure 68: Germany GDP – Composition of 2023, By Sector of Origin
Figure 69: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 70: Italy Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 71: Italy GDP and Population, 2023-2030 ($)
Figure 72: Italy GDP – Composition of 2023, By Sector of Origin
Figure 73: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 74: France Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 75: France GDP and Population, 2023-2030 ($)
Figure 76: France GDP – Composition of 2023, By Sector of Origin
Figure 77: France Export and Import Value & Volume, 2023-2030 ($)
Figure 78: Netherlands Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 79: Netherlands GDP and Population, 2023-2030 ($)
Figure 80: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 81: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 82: Belgium Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 83: Belgium GDP and Population, 2023-2030 ($)
Figure 84: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 85: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 86: Spain Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 87: Spain GDP and Population, 2023-2030 ($)
Figure 88: Spain GDP – Composition of 2023, By Sector of Origin
Figure 89: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 90: Denmark Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 91: Denmark GDP and Population, 2023-2030 ($)
Figure 92: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 93: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 94: APAC Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 95: China Genetic Biomarkers Market Value & Volume, 2023-2030
Figure 96: China GDP and Population, 2023-2030 ($)
Figure 97: China GDP – Composition of 2023, By Sector of Origin
Figure 98: China Export and Import Value & Volume, 2023-2030 ($) Genetic Biomarkers Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 99: Australia Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 100: Australia GDP and Population, 2023-2030 ($)
Figure 101: Australia GDP – Composition of 2023, By Sector of Origin
Figure 102: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 103: South Korea Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 104: South Korea GDP and Population, 2023-2030 ($)
Figure 105: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 106: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 107: India Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 108: India GDP and Population, 2023-2030 ($)
Figure 109: India GDP – Composition of 2023, By Sector of Origin
Figure 110: India Export and Import Value & Volume, 2023-2030 ($)
Figure 111: Taiwan Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 112: Taiwan GDP and Population, 2023-2030 ($)
Figure 113: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 114: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 115: Malaysia Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 116: Malaysia GDP and Population, 2023-2030 ($)
Figure 117: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 118: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 119: Hong Kong Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 120: Hong Kong GDP and Population, 2023-2030 ($)
Figure 121: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 122: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 123: Middle East & Africa Genetic Biomarkers Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 124: Russia Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 125: Russia GDP and Population, 2023-2030 ($)
Figure 126: Russia GDP – Composition of 2023, By Sector of Origin
Figure 127: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 128: Israel Genetic Biomarkers Market Value & Volume, 2023-2030 ($)
Figure 129: Israel GDP and Population, 2023-2030 ($)
Figure 130: Israel GDP – Composition of 2023, By Sector of Origin
Figure 131: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 132: Entropy Share, By Strategies, 2023-2030* (%) Genetic Biomarkers Market
Figure 133: Developments, 2023-2030* Genetic Biomarkers Market
Figure 134: Company 1 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 135: Company 1 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 136: Company 1 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 137: Company 2 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 138: Company 2 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 139: Company 2 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 140: Company 3 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 141: Company 3 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 142: Company 3 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 143: Company 4 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 144: Company 4 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 145: Company 4 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 146: Company 5 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 147: Company 5 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 148: Company 5 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 149: Company 6 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 150: Company 6 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 151: Company 6 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 152: Company 7 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 153: Company 7 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 154: Company 7 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 155: Company 8 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 156: Company 8 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 157: Company 8 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 158: Company 9 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 159: Company 9 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 160: Company 9 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 161: Company 10 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 162: Company 10 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 163: Company 10 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 164: Company 11 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 165: Company 11 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 166: Company 11 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 167: Company 12 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 168: Company 12 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 169: Company 12 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 170: Company 13 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 171: Company 13 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 172: Company 13 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 173: Company 14 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 174: Company 14 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 175: Company 14 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)
Figure 176: Company 15 Genetic Biomarkers Market Net Revenue, By Years, 2023-2030* ($)
Figure 177: Company 15 Genetic Biomarkers Market Net Revenue Share, By Business segments, 2023 (%)
Figure 178: Company 15 Genetic Biomarkers Market Net Sales Share, By Geography, 2023 (%)

The Genetic Biomarkers Market is projected to grow at 9.7% CAGR during the forecast period 2024-2030.

The Genetic Biomarkers Market size is estimated to be $21.2 billion in 2023 and is projected to reach $37 billion by 2030

The leading players in the Genetic Biomarkers Market are Illumina Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Abbott, F. Hoffmann-La Roche and Others

Utilizing genetic biomarkers for early detection and risk assessment of complex diseases like cancer and cardiovascular conditions and increasing funding in biopharmaceutical research are some of the major Genetic Biomarkers Market trends in the industry which will create growth opportunities for the market during the forecast period.

The rising prevalence of chronic diseases, growing awareness of early disease detection and the launch of biomarker tests are the driving factors of the market.